NEUARTIGE PEG-DERIVATE

European patent · EP3228650 · In force

Register entry

Publication number
EP3228650
Application number
EP15864609
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 3, 2015
Published
Oct 11, 2017
Granted
Mar 9, 2022
Protection ends at the latest
Dec 2, 2035
Next annual fee due
Dec 31, 2026
IPC classes
C08G 65/333 (2006.01)
A61K 31/407 (2006.01)
A61K 31/496 (2006.01)
A61K 31/7068 (2006.01)
A61P 35/00 (2006.01)
Priority
JP 2014246110 04.12.2014
PCT application
PCT/JP2015/084068 03.12.2015
PCT publication
WO2016/088858 09.06.2016
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 18, 2023

    Change

    Published in Swissreg on 18.01.2023

  5. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  6. Mar 9, 2022

    Granted

    Published in Swissreg on 09.03.2022

Parties

Holder

Delta-Fly Pharma, Inc.

37-5, Nishikino, Miyajima Kawauchi-cho, Tokushima-shi Tokushima 771-0116, JP

Inventor

FUKUSHIMA, Masakazu

Otsu-shi Shiga 520-0863, JP

ESHIMA, Kiyoshi

Tokushima-shi Tokushima 771-0116, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.